Matches in SemOpenAlex for { <https://semopenalex.org/work/W3142018081> ?p ?o ?g. }
- W3142018081 abstract "The objective was to evaluate the clinical characteristics, management and two-year outcomes of patients with newly diagnosed non-valvular atrial fibrillation at risk for stroke in Nordic countries.We examined the baseline characteristics, antithrombotic treatment, and two-year clinical outcomes of patients from four Nordic countries.A total of 52,080 patients were enrolled in the GARFIELD-AF. Out of 29,908 European patients, 2,396 were recruited from Nordic countries. The use of oral anticoagulants, alone or in combination with antiplatelet (AP), was higher in Nordic patients in all CHA2DS2-VASc categories: 0-1 (72.8% vs 60.3%), 2-3 (78.7% vs 72.9%) and ≥4 (79.2% vs 74.1%). In Nordic patients, NOAC ± AP was more frequently prescribed (32.0% vs 27.7%) and AP monotherapy was less often prescribed (10.4% vs 18.2%) when compared with Non-Nordic European patients. The rates (per 100 patient years) of all-cause mortality and non-haemorrhagic stroke/systemic embolism (SE) were similar in Nordic and Non-Nordic European patients [3.63 (3.11-4.23) vs 4.08 (3.91-4.26), p value = .147] and [0.98 (0.73-1.32) vs 1.02 (0.93-1.11), p value = .819], while major bleeding was significantly higher [1.66 (1.32-2.09) vs 1.01 (0.93-1.10), p value < .001].Nordic patients had significantly higher major bleeding than Non-Nordic-European patients. In contrast, rates of all-cause mortality and non-haemorrhagic stroke/SE were comparable.Unique identifier: NCT01090362. URL: http://www.clinicaltrials.gov.Nordic countries had significantly higher major bleeding than Non-Nordic-European countries. Rates of mortality and non-haemorrhagic stroke/SE were similar ." @default.
- W3142018081 created "2021-04-13" @default.
- W3142018081 creator A5003298952 @default.
- W3142018081 creator A5013409359 @default.
- W3142018081 creator A5014280780 @default.
- W3142018081 creator A5017114622 @default.
- W3142018081 creator A5022363985 @default.
- W3142018081 creator A5029835988 @default.
- W3142018081 creator A5033377615 @default.
- W3142018081 creator A5048854853 @default.
- W3142018081 creator A5057769576 @default.
- W3142018081 creator A5059335867 @default.
- W3142018081 creator A5065723634 @default.
- W3142018081 creator A5072026482 @default.
- W3142018081 creator A5073848984 @default.
- W3142018081 creator A5076961983 @default.
- W3142018081 creator A5079494067 @default.
- W3142018081 creator A5081330228 @default.
- W3142018081 creator A5087186248 @default.
- W3142018081 creator A5088006074 @default.
- W3142018081 date "2021-01-01" @default.
- W3142018081 modified "2023-10-16" @default.
- W3142018081 title "Risk profile, antithrombotic treatment and clinical outcomes of patients in Nordic countries with atrial fibrillation – results from the GARFIELD-AF registry" @default.
- W3142018081 cites W1971505725 @default.
- W3142018081 cites W2013311776 @default.
- W3142018081 cites W2033102959 @default.
- W3142018081 cites W2036605610 @default.
- W3142018081 cites W2059231500 @default.
- W3142018081 cites W2062731392 @default.
- W3142018081 cites W2070601915 @default.
- W3142018081 cites W2097854437 @default.
- W3142018081 cites W2114775432 @default.
- W3142018081 cites W2121721334 @default.
- W3142018081 cites W2136489990 @default.
- W3142018081 cites W2137434301 @default.
- W3142018081 cites W2141347595 @default.
- W3142018081 cites W2141913785 @default.
- W3142018081 cites W2145391133 @default.
- W3142018081 cites W2147018083 @default.
- W3142018081 cites W2148056560 @default.
- W3142018081 cites W2149388786 @default.
- W3142018081 cites W2151074096 @default.
- W3142018081 cites W2159193915 @default.
- W3142018081 cites W2159975225 @default.
- W3142018081 cites W2162508946 @default.
- W3142018081 cites W2162586165 @default.
- W3142018081 cites W2165762371 @default.
- W3142018081 cites W2775903766 @default.
- W3142018081 cites W2784408897 @default.
- W3142018081 cites W2883155848 @default.
- W3142018081 cites W4205645630 @default.
- W3142018081 doi "https://doi.org/10.1080/07853890.2021.1893897" @default.
- W3142018081 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8023647" @default.
- W3142018081 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33818226" @default.
- W3142018081 hasPublicationYear "2021" @default.
- W3142018081 type Work @default.
- W3142018081 sameAs 3142018081 @default.
- W3142018081 citedByCount "0" @default.
- W3142018081 crossrefType "journal-article" @default.
- W3142018081 hasAuthorship W3142018081A5003298952 @default.
- W3142018081 hasAuthorship W3142018081A5013409359 @default.
- W3142018081 hasAuthorship W3142018081A5014280780 @default.
- W3142018081 hasAuthorship W3142018081A5017114622 @default.
- W3142018081 hasAuthorship W3142018081A5022363985 @default.
- W3142018081 hasAuthorship W3142018081A5029835988 @default.
- W3142018081 hasAuthorship W3142018081A5033377615 @default.
- W3142018081 hasAuthorship W3142018081A5048854853 @default.
- W3142018081 hasAuthorship W3142018081A5057769576 @default.
- W3142018081 hasAuthorship W3142018081A5059335867 @default.
- W3142018081 hasAuthorship W3142018081A5065723634 @default.
- W3142018081 hasAuthorship W3142018081A5072026482 @default.
- W3142018081 hasAuthorship W3142018081A5073848984 @default.
- W3142018081 hasAuthorship W3142018081A5076961983 @default.
- W3142018081 hasAuthorship W3142018081A5079494067 @default.
- W3142018081 hasAuthorship W3142018081A5081330228 @default.
- W3142018081 hasAuthorship W3142018081A5087186248 @default.
- W3142018081 hasAuthorship W3142018081A5088006074 @default.
- W3142018081 hasBestOaLocation W31420180811 @default.
- W3142018081 hasConcept C126322002 @default.
- W3142018081 hasConcept C127413603 @default.
- W3142018081 hasConcept C164705383 @default.
- W3142018081 hasConcept C2777015399 @default.
- W3142018081 hasConcept C2777185221 @default.
- W3142018081 hasConcept C2779161974 @default.
- W3142018081 hasConcept C2780645631 @default.
- W3142018081 hasConcept C71924100 @default.
- W3142018081 hasConcept C78519656 @default.
- W3142018081 hasConceptScore W3142018081C126322002 @default.
- W3142018081 hasConceptScore W3142018081C127413603 @default.
- W3142018081 hasConceptScore W3142018081C164705383 @default.
- W3142018081 hasConceptScore W3142018081C2777015399 @default.
- W3142018081 hasConceptScore W3142018081C2777185221 @default.
- W3142018081 hasConceptScore W3142018081C2779161974 @default.
- W3142018081 hasConceptScore W3142018081C2780645631 @default.
- W3142018081 hasConceptScore W3142018081C71924100 @default.
- W3142018081 hasConceptScore W3142018081C78519656 @default.
- W3142018081 hasLocation W31420180811 @default.
- W3142018081 hasLocation W31420180812 @default.
- W3142018081 hasLocation W31420180813 @default.
- W3142018081 hasLocation W31420180814 @default.